Search Results 3821-3830 of 26291 for oral

  1. Non Clinical Trials - Mayo Clinic Research

    Venetoclax is an oral Bcl-2 family protein inhibitor. It targets the B-cell lymphoma 2 (BCL-2) protein, which supports cancer cell growth and is overexpressed ...

  2. Randa Tao, M.D. - Doctors and Medical Staff - Mayo Clinic

    Tao was a panel member on the National Comprehensive Cancer Network (NCCN) Hodgkin Lymphoma Guidelines, serves as an oral board examiner for the American ...

  3. Neuroendocrine tumors - Doctors and departments - Mayo Clinic

    ... Oral biopsy, Cancer, Head and neck cancer, Facial fracture, Osteoradionecrosis, Chondrosarcoma, Nasal and paranasal tumors, Thyroid cancer, Soft tissue ...

  4. Neuroendocrine tumors - Doctors and departments - Mayo Clinic

    ... Oral biopsy, Cancer, Head and neck cancer, Facial fracture, Osteoradionecrosis, Chondrosarcoma, Nasal and paranasal tumors, Thyroid cancer, Soft tissue ...

  5. A Study to Evaluate Brigatinib Before Brain Irradiation - Mayo Clinic

    Ability to take and retain oral medications. Age ≥ 18 years. Patients with ALK+ lung cancer with evidence of ≥1 previously untreated brain metastases on ...

  6. A Research Study to Evaluate Safety and Efficacy of DUR-928 in Subjects With Primary Sclerosing Cholangitis (PSC) - Mayo Clinic

    Use of oral prednisolone > 10 mg/day and/or hospitalization for IBD within 90 days prior to Day 1 are disallowed. AST, ALT, and Total Bilirubin ...

  7. InSpace Accelerated Rehabilitation Study (iAccelerate) - Mayo Clinic

    - Oral analgesics - Anti-inflammatory medication (e.g., ibuprofen, naproxen) - Corticosteroid injection(s) - Physical therapy - Activity modification - Rest ...

  8. C-Section Clinical Trials - Mayo Clinic Research

    Oral carbohydrate loading has been shown to attenuate the development of insulin resistance in the non-pregnant population undergoing many different types of ...

  9. Johnny Yi, M.D. - Doctors and Medical Staff - Mayo Clinic

    Oral Board ExaminerSubspecialty Certifying Exam, American Board of Obstetrics and Gynecology. 2025 - present. MemberEducation Committee, Executive Operations ...

  10. Open-Label Study of the CDK4/6 Inhibitor SPH4336 in Subjects With Locally Advanced or Metastatic Liposarcomas - Mayo Clinic

    Sterile or willing to use effective contraception (approved hormonal contraceptive such as oral ... oral therapy (e.g., ulcerative disease, uncontrolled nausea, ...